Resistin-like molecule-b (RELMb) is a novel secretory protein from intestinal goblet cells and participates in epithelial differentiation, tumor occurrence, and immune response. RELMb is absent in normal gastric mucosa but is abundantly expressed in gastric carcinoma tissues, and is correlated with tumor invasion and metastasis. Epithelial-mesenchymal transition (EMT) is an important mechanism governing tumor cell invasion. This study thus investigated the modulation of RELMb in gastric cancer metastasis and its correlation with EMT.
Background
The members of the resistin-like molecules (RELMs) family share the same cysteine structure. As an important family member, RELMb is secreted by intestinal goblet cells [1] . RELMb has been shown to be abundantly expressed in gastric carcinoma tissues and is closely correlated with biological behaviors and clinical features of tumors [2] . Endothelial-mesenchymal transition (EMT), an important process underlying tumor invasion and metastasis, requires the participation of multiple cytokines for the transformation of epithelial cell genes [3] . This study transfected RELMb-expressing vector into gastric carcinoma cell line and normal gastric mucosa epithelial cells, on which cell invasion and metastatic abilities, along with EMT-related factors, including E-cadherin, N-cadherin, Snail, Vimentin, were measured.
Material and Methods

Cell culture and transfection
Gastric carcinoma cell line AGS and normal gastric mucosa epithelial cell line GES1 were purchased from Baili Biotech (Shanghai, China). Cells were cultured in RPMI1640 medium (Gibco, USA) in a humidified chamber at 37°C perfused with 5% CO 2 .
Recombinant vector pClR1-RELMb and expressing vector peDNA3.1Zeo(+) were digested by EcoRI enzyme, followed by gel purification and de-phosphorylation. Log-phased cells were seeded into 6-well plates in 3 groups: blank control (no transfection), empty vector pcDNA3.1/Zeo(+) transfection, and pcDNA3.1-RELMb transfected groups. The transfection was performed using the Lipofeoatmine2000 kit (Invitrogen, USA) following the manufacturer's instructions.
Real-time PCR
Log-phased AGS and GES1 cells were collected, along with transfected AGS cells. Total RNA was extracted by use of the Trizol kit (Invitrogen, USA) following the manual instruction. After quantification by A260/A280 ratio, 200 ng RNA was used as the template for synthesizing cDNA using polyA tail. PCR amplification was performed using a fluorescent quantitative PCR kit (Sangon, China). Specific primers were designed as follows: " RELMb: 5'-CACCATGAAG CCTACACTGTGTTTCC-3' (Forward), 5'-TTAAACCATTCGGCAGCAGCGG-3' (Reverse); GAPDH: 5'-GCCAAGGTCATCCATGACAACTTTGG-3' (Forward), 5'-GCCTGCTTCACCACC TTCTTGATGTC-3' (Reverse)". PCR amplification consisted of 40 cycles each containing 95°C denature for 30 s, 60°C annealing for 30 s and 72°C elongation for 45 s. The relative mRNA expression was calculated by comparative Ct method.
Transwell chamber assay
For evaluating invasion ability, A Transwell chamber (Millipore, USA) was pre-coated with Matrigel at 4°C overnight, followed by incubation of serum-free medium on the artificial membrane at 37°C for 1 h. Transfected AGS cells were seeded in the upper chamber, while RPMI1640 medium was added into the lower chamber. At the endpoint, cells were stained by Giemsa and observed under an inverted microscope. For evaluating cell migration ability, cells were seeded in the chamber in the same manner without an artificial basal membrane. Cell invasion and migration ability was assessed through counting the numbers of positive-staining cells under a microscope.
Western blotting
Transfected AGS cells were collected for total protein extraction. After quantification, proteins were separated in 8% SDS-PAGE (40 μg per well) and were transferred to the PVDF membrane. The
Group
RELMb transfected AGS cell GES1 cell , or mouse anti-human Snail monoclonal antibody (1:700, Cell Signaling, USA) was applied for 4°C overnight incubation. After being cultured in secondary antibody and development, the membrane was exposed and the image was captured and analyzed. Intensity of positive bands was quantified using Image J software. Protein expression was quantified as a ratio to loading control (b-actin or GADPH).
Statistical analysis
We used the SPSS 17.0 software package to process all collected data. Measurement data are presented as mean ± standard deviation (SD), while enumeration data were compared by chi-square test. The t test was used for between-groupcomparisons. Statistical significance was defined when p<0.05.
Results
RELMb expression in transfected AGS cells
Using real-time PCR to detect the mRNA level of RELMb in AGS cells after transfection, we found significantly elevated RELMb mRNA level after transfection (p<0.05, Table 1, Figure 1 ).
Cell migration and invasion assay
Using Transwell assay to detect migration and invasion ability of RELMb-transfected AGS cells, results showed significantly 
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RELMb protein expression in transfected AGS cells
Western blot assay showed significantly elevated RELMb protein levels in RELMb-transfected AGS cells compared to blank AGS cells or GES1 cells (p<0.05, Table 2, Figure 3 ).
EMT-related protein levels
We further tested the expression of EMT-related proteins, including E-cadherin, N-cadherin, Snail, and Vimentin, in those AGS cells transfected with RELMb. Results showed significantly elevated expression of N-cadherin, Snail, and Vimentin in post-transfected cells, while E-cadherin expression was depressed (p<0.05, Table 3, Figure 4 ).
Discussion
The RELMs family is a group of secretory proteins containing abundant cysteine. It consists of 4 major family members: RELMa/HIMF, RELMb/FIZZ2, Resistin/FIZZ3, and RELMg/FIZZ4 [4, 5] . RELMb was first discovered in epithelial cells of the mouse intestine, while human RELMb is mainly distributed in pulmonary vessels, bronchial mucosa epithelial cells, intestinal epithelial cells, kidney, and adrenal glands [6] . Studies have confirmed the elevated RELMb secretion from intestinal goblet cells in mice infected with nematodes, and such secretion was mediated by cytokines, including IL-4, IL-13, and STAT6 for specific mucosal immunity and gastrointestinal defense [7] . People with elevated plasma RELMb levels normally have smoking history or deficits of exercise, both of which are independent risk factors for gastric carcinoma [8] .
In this study we transfected RELMb-expressing vector into gastric cancer AGS cells, in parallel with blank AGS and normal gastric mucosal epithelial GES1 cells as controls. Realtime PCR and Western blotting showed significantly elevated Transwell assay demonstrated increased migration and invasion abilities of transfected AGS cells. A further comparison showed that, even in intact AGS cells, RELMb expression level was still higher than in GES1 cells. These data collectively show that over-expression of RELMb can facilitate the migration and invasion of gastric carcinoma cells. It has been discovered that RELMb is up-regulated in colorectal cancer tissues compared to those in normal intestine epithelial cells. Moreover, serum RELMb in gastrointestinal tumor patients was positively correlated with tumor stage and malignancy [9, 10] . A systematic study of 156 gastric cancer patients also revealed the correlation between higher RELMb level and unfavorable prognosis, possibly due to the elevated expression of RELMb in gastric carcinoma tissues and further induction of matrix metalloproteinase-2 (MMP-2) and MMP-9 from mononuclear cells for tumor progression [11] . Esophagus carcinoma and Barrett esophageal atypical proliferation cells also had elevated serum RELMb levels with advancement of TNM stage, making it a potential marker for esophageal squamous carcinoma. RELMb has also been suggested to facilitate mitosis, proliferation, and migration of fibroblasts [12] . The binding of CDX-2 onto human RELMb can facilitate proliferation of intestinal epithelial cells, modulate cell cycle, and potentiate cell-to-cell adhesion, making the RELMb level negatively correlated with tumor differentiation stage [13, 14] .
EMT has been shown to be closely related with invasion and migration of malignant tumors, mainly to due to the acquirement of mesenchymal cells in epithelial-derived cells [15] . As a tumor-suppressor gene, E-cadherin can limit the peripheral infiltration of tumor cells, along with the invasive migration [16] . N-cadherin, however, mainly inhibits cell apoptosis and is positively expressed in the formation and differentiation of embryonic tissues [17] . Vimentin is expressed in mesenchymal tissues and is related with tumor invasion and metastasis, making it an important cytokine in aggravating tumor malignancy [18] . The incidence of gastric carcinoma in China is increasing. Due to its insidious onset, gastric cancer is usually diagnosed at its late stage. With the progression of disease, there will be aggravated tumor cell invasion, which can be reflected by EMT as decreased epithelial marker E-cadherin and increased mesenchymal markers N-cadherin, Snail, and Vimentin [19, 20] . In this study, we found elevated protein levels of N-cadherin, Snail, and Vimentin in RELMb-transfected AGS cells, in addition to decreased expression of E-cadherin, all of which suggest the progression of EMT. We thus propose that the down-regulation of RELMb may impede the occurrence of EMT, although further studies are required for substantiation.
Conclusions
RELMb is abundantly expressed in gastric carcinoma cells, and can facilitate the invasion and migration of tumor cells via facilitating EMT, as it increased expression of EMT-related proteins, including N-cadherin, Snail, and Vimentin, in addition to inhibiting E-cadherin expression. The early and timely detection of RELMb, therefore, may provide a novel diagnostic index and/or drug target for gastric cancer.
